BLRX Stock Analysis: Buy, Sell, or Hold?
BLRX - BioLineRX Ltd
$3.25
-0.13 (-3.71%)
▼
5d:
-0.15%
30d:
+6.05%
90d:
+23.38%
BUY
MODERATE Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: May 27, 2026
0d
Get Alerted When BLRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BLRX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: BLRX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: BLRX is currently trading at $3.25, which is considered fair relative to its 30-day fair value range of $2.93 to $3.44.
Technical Outlook: Technically, BLRX is in a uptrend. Immediate support is located at $2.99, while resistance sits at $3.60. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $17.50 (+439.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BLRX is in a uptrend. Immediate support is located at $2.99, while resistance sits at $3.60. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $17.50 (+439.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.93 -
$3.44
Company Quality Score
50/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
64.2%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BEARISH: Downward momentum (-3.7%)
- BULLISH: Trading 439.3% below Wall St target ($17.50)
Trading Range Analysis
30-Day Trading Range
$2.93 -
$3.44
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.99
Resistance Level
$3.60
Current Trend
Uptrend
Technical data as of
Jun 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.07
Wall Street Target
$17.50
(+439.3%)
Revenue Growth (YoY)
87.1%
Share & Embed Analysis
Last updated: June 15, 2026 10:31 PM ET
Data refreshes hourly during market hours. Next update: 11:31 PM
Data refreshes hourly during market hours. Next update: 11:31 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 52 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 63 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$103 | 58 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$123 | 52 HOLD |
